Expression of receptor for advanced glycation end products in sarcoid granulomas

Ilaria Campo, Patrizia Morbini, Michele Zorzetto, Carmine Tinelli, Enrico Brunetta, Chiara Villa, Cristina Bombieri, Mariaclara Cuccia, Carlo Agostini, Valeria Bozzi, Angelica Facoetti, Ilaria Ferrarotti, Paola Mazzola, Roberta Scabini, Gianpietro Semenzato, Pier Franco Pignatti, Ernesto Pozzi, Maurizio Luisetti

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Rationale: The receptor for advanced glycation end products (RAGE) engages a number of ligands implicated in inflammatory processes. The RAGE coding gene maps to the 6p21.32 region, close to the genes DRB1 and BTNL2, which are associated with sarcoidosis. Objectives: We investigated a possible implication of RAGE in sarcoid granulomas. Methods: RAGE and major ligands (N-ε-carboxy-methyl-lysine [CML], S100A12, and S100B) expression was investigated by immunostaining of 99 paraffin-embedded biopsies of sarcoid tissues, and expression patterns were determined. Among the three RAGE gene single-nucleotide polymorphisms investigated, -374 T/A was selected, characterized in terms of transcriptional effect (immunocytochemistry and real-time polymerase chain reaction), and its frequency was determined in DNA extracted from biopsies. Measurements and Results: RAGE, CML, S100A12, and S100B immunoreactivity was observed in all sarcoid granulomas, although at different intensities. The degree of RAGE expression significantly correlated with the degree of S100A12 expression. The -374 TT/AT genotypes, associated with higher RAGE transcriptional activity, were more frequent in the sarcoidosis biopsy group than in control subjects, and the association was confirmed in a second, independent series of 101 patients with sarcoidosis. Conclusions: We showed the association of RAGE and its ligands with sarcoidosis and suggest that an intrinsic genetic factor could be in part involved in its expression. In Italian patients, the -374 T/A polymorphism seems to be significantly associated with this disease.

Original languageEnglish
Pages (from-to)498-506
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume175
Issue number5
DOIs
Publication statusPublished - Mar 1 2007

Fingerprint

Granuloma
Sarcoidosis
Ligands
Biopsy
Lysine
Genes
Advanced Glycosylation End Product-Specific Receptor
Intrinsic Factor
Paraffin
Single Nucleotide Polymorphism
Real-Time Polymerase Chain Reaction
Immunohistochemistry
Genotype
Control Groups
DNA

Keywords

  • Genetics
  • Immunohistochemistry
  • Ligands
  • Real-time polymerase chain reaction

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Expression of receptor for advanced glycation end products in sarcoid granulomas. / Campo, Ilaria; Morbini, Patrizia; Zorzetto, Michele; Tinelli, Carmine; Brunetta, Enrico; Villa, Chiara; Bombieri, Cristina; Cuccia, Mariaclara; Agostini, Carlo; Bozzi, Valeria; Facoetti, Angelica; Ferrarotti, Ilaria; Mazzola, Paola; Scabini, Roberta; Semenzato, Gianpietro; Pignatti, Pier Franco; Pozzi, Ernesto; Luisetti, Maurizio.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 175, No. 5, 01.03.2007, p. 498-506.

Research output: Contribution to journalArticle

Campo, I, Morbini, P, Zorzetto, M, Tinelli, C, Brunetta, E, Villa, C, Bombieri, C, Cuccia, M, Agostini, C, Bozzi, V, Facoetti, A, Ferrarotti, I, Mazzola, P, Scabini, R, Semenzato, G, Pignatti, PF, Pozzi, E & Luisetti, M 2007, 'Expression of receptor for advanced glycation end products in sarcoid granulomas', American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 5, pp. 498-506. https://doi.org/10.1164/rccm.200601-136OC
Campo, Ilaria ; Morbini, Patrizia ; Zorzetto, Michele ; Tinelli, Carmine ; Brunetta, Enrico ; Villa, Chiara ; Bombieri, Cristina ; Cuccia, Mariaclara ; Agostini, Carlo ; Bozzi, Valeria ; Facoetti, Angelica ; Ferrarotti, Ilaria ; Mazzola, Paola ; Scabini, Roberta ; Semenzato, Gianpietro ; Pignatti, Pier Franco ; Pozzi, Ernesto ; Luisetti, Maurizio. / Expression of receptor for advanced glycation end products in sarcoid granulomas. In: American Journal of Respiratory and Critical Care Medicine. 2007 ; Vol. 175, No. 5. pp. 498-506.
@article{069f73f4d2c547dc9164415f5a7c8847,
title = "Expression of receptor for advanced glycation end products in sarcoid granulomas",
abstract = "Rationale: The receptor for advanced glycation end products (RAGE) engages a number of ligands implicated in inflammatory processes. The RAGE coding gene maps to the 6p21.32 region, close to the genes DRB1 and BTNL2, which are associated with sarcoidosis. Objectives: We investigated a possible implication of RAGE in sarcoid granulomas. Methods: RAGE and major ligands (N-ε-carboxy-methyl-lysine [CML], S100A12, and S100B) expression was investigated by immunostaining of 99 paraffin-embedded biopsies of sarcoid tissues, and expression patterns were determined. Among the three RAGE gene single-nucleotide polymorphisms investigated, -374 T/A was selected, characterized in terms of transcriptional effect (immunocytochemistry and real-time polymerase chain reaction), and its frequency was determined in DNA extracted from biopsies. Measurements and Results: RAGE, CML, S100A12, and S100B immunoreactivity was observed in all sarcoid granulomas, although at different intensities. The degree of RAGE expression significantly correlated with the degree of S100A12 expression. The -374 TT/AT genotypes, associated with higher RAGE transcriptional activity, were more frequent in the sarcoidosis biopsy group than in control subjects, and the association was confirmed in a second, independent series of 101 patients with sarcoidosis. Conclusions: We showed the association of RAGE and its ligands with sarcoidosis and suggest that an intrinsic genetic factor could be in part involved in its expression. In Italian patients, the -374 T/A polymorphism seems to be significantly associated with this disease.",
keywords = "Genetics, Immunohistochemistry, Ligands, Real-time polymerase chain reaction",
author = "Ilaria Campo and Patrizia Morbini and Michele Zorzetto and Carmine Tinelli and Enrico Brunetta and Chiara Villa and Cristina Bombieri and Mariaclara Cuccia and Carlo Agostini and Valeria Bozzi and Angelica Facoetti and Ilaria Ferrarotti and Paola Mazzola and Roberta Scabini and Gianpietro Semenzato and Pignatti, {Pier Franco} and Ernesto Pozzi and Maurizio Luisetti",
year = "2007",
month = "3",
day = "1",
doi = "10.1164/rccm.200601-136OC",
language = "English",
volume = "175",
pages = "498--506",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society - AJRCCM",
number = "5",

}

TY - JOUR

T1 - Expression of receptor for advanced glycation end products in sarcoid granulomas

AU - Campo, Ilaria

AU - Morbini, Patrizia

AU - Zorzetto, Michele

AU - Tinelli, Carmine

AU - Brunetta, Enrico

AU - Villa, Chiara

AU - Bombieri, Cristina

AU - Cuccia, Mariaclara

AU - Agostini, Carlo

AU - Bozzi, Valeria

AU - Facoetti, Angelica

AU - Ferrarotti, Ilaria

AU - Mazzola, Paola

AU - Scabini, Roberta

AU - Semenzato, Gianpietro

AU - Pignatti, Pier Franco

AU - Pozzi, Ernesto

AU - Luisetti, Maurizio

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Rationale: The receptor for advanced glycation end products (RAGE) engages a number of ligands implicated in inflammatory processes. The RAGE coding gene maps to the 6p21.32 region, close to the genes DRB1 and BTNL2, which are associated with sarcoidosis. Objectives: We investigated a possible implication of RAGE in sarcoid granulomas. Methods: RAGE and major ligands (N-ε-carboxy-methyl-lysine [CML], S100A12, and S100B) expression was investigated by immunostaining of 99 paraffin-embedded biopsies of sarcoid tissues, and expression patterns were determined. Among the three RAGE gene single-nucleotide polymorphisms investigated, -374 T/A was selected, characterized in terms of transcriptional effect (immunocytochemistry and real-time polymerase chain reaction), and its frequency was determined in DNA extracted from biopsies. Measurements and Results: RAGE, CML, S100A12, and S100B immunoreactivity was observed in all sarcoid granulomas, although at different intensities. The degree of RAGE expression significantly correlated with the degree of S100A12 expression. The -374 TT/AT genotypes, associated with higher RAGE transcriptional activity, were more frequent in the sarcoidosis biopsy group than in control subjects, and the association was confirmed in a second, independent series of 101 patients with sarcoidosis. Conclusions: We showed the association of RAGE and its ligands with sarcoidosis and suggest that an intrinsic genetic factor could be in part involved in its expression. In Italian patients, the -374 T/A polymorphism seems to be significantly associated with this disease.

AB - Rationale: The receptor for advanced glycation end products (RAGE) engages a number of ligands implicated in inflammatory processes. The RAGE coding gene maps to the 6p21.32 region, close to the genes DRB1 and BTNL2, which are associated with sarcoidosis. Objectives: We investigated a possible implication of RAGE in sarcoid granulomas. Methods: RAGE and major ligands (N-ε-carboxy-methyl-lysine [CML], S100A12, and S100B) expression was investigated by immunostaining of 99 paraffin-embedded biopsies of sarcoid tissues, and expression patterns were determined. Among the three RAGE gene single-nucleotide polymorphisms investigated, -374 T/A was selected, characterized in terms of transcriptional effect (immunocytochemistry and real-time polymerase chain reaction), and its frequency was determined in DNA extracted from biopsies. Measurements and Results: RAGE, CML, S100A12, and S100B immunoreactivity was observed in all sarcoid granulomas, although at different intensities. The degree of RAGE expression significantly correlated with the degree of S100A12 expression. The -374 TT/AT genotypes, associated with higher RAGE transcriptional activity, were more frequent in the sarcoidosis biopsy group than in control subjects, and the association was confirmed in a second, independent series of 101 patients with sarcoidosis. Conclusions: We showed the association of RAGE and its ligands with sarcoidosis and suggest that an intrinsic genetic factor could be in part involved in its expression. In Italian patients, the -374 T/A polymorphism seems to be significantly associated with this disease.

KW - Genetics

KW - Immunohistochemistry

KW - Ligands

KW - Real-time polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=33847637702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847637702&partnerID=8YFLogxK

U2 - 10.1164/rccm.200601-136OC

DO - 10.1164/rccm.200601-136OC

M3 - Article

C2 - 17170388

AN - SCOPUS:33847637702

VL - 175

SP - 498

EP - 506

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 5

ER -